E. Schott
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 30
- Hepatitis C virus research 19
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Diseases and Immunity 3
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 7
- Co-authors
- Olivier Rosmorduc (4 shared papers)Bruno Sangro (5 shared papers)Jaclyn Neely (2 shared papers)Su Pin Choo (2 shared papers)Richard S. Finn (2 shared papers)Ann‐Lii Cheng (2 shared papers)Julien Edeline (2 shared papers)Masatoshi Kudo (2 shared papers)
- Journals
- Journal of Hepatology (18 papers)Annals of Oncology (4 papers)Journal of Viral Hepatitis (2 papers)Hepatology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
E. Schott
33 papers receiving 761 citations
E. Schott's Hit Papers
Peers
Comparison fields: 5 of 54
- Hepatology 510
- Oncology 253
- Pathology and Forensic Medicine 121
- Immunology 134
- Epidemiology 165
Countries citing papers authored by E. Schott
This map shows the geographic impact of E. Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schott more than expected).
Fields of papers citing papers by E. Schott
This network shows the impact of papers produced by E. Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schott. The network helps show where E. Schott may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Schott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) Hit paper breakdown → | 2019 | 505 |
| 2 | 2007 | 66 | |
| 3 | 2020 | 45 | |
| 4 | 2018 | 32 | |
| 5 | 2011 | 17 | |
| 6 | 2011 | 14 | |
| 7 | 2018 | 10 | |
| 8 | 2015 | 9 | |
| 9 | 2005 | 9 | |
| 10 | 2011 | 8 | |
| 11 | 2014 | 7 | |
| 12 | 2016 | 7 | |
| 13 | Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection. | 2004 | 5 |
| 14 | 2008 | 5 | |
| 15 | 2013 | 4 | |
| 16 | 2016 | 4 | |
| 17 | 2011 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2016 | 3 | |
| 20 | 2015 | 2 |
About E. Schott
E. Schott is a scholar working on Hepatology, Epidemiology, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 775 indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (7 papers), Liver Diseases and Immunity (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Hepatology (510 citations), Oncology (253 citations), Pathology and Forensic Medicine (121 citations), Immunology (134 citations) and Epidemiology (165 citations). E. Schott has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Olivier Rosmorduc, Bruno Sangro, Jaclyn Neely, Su Pin Choo, Richard S. Finn, Ann‐Lii Cheng, Julien Edeline, Masatoshi Kudo, Philippe Merle and Thomas Yau. Their work appears in journals such as Journal of Hepatology, Annals of Oncology, Journal of Viral Hepatitis, Hepatology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.